EUVIMEDEUVIMED entdecken
Open Access · CC0

In depth characterization of midbrain organoids derived from wild type iPSC lines

Ivan Pavlinov iD, Mitali Tambe, Joshua Abbott iD, Ha Nam Nguyen, Miao Xu, Manisha Pradhan, Atena Farkhondeh, Wei Zheng iD

PLOS ONE · 20.10.2023 · 18 (10) · e0292926

DOI: 10.1371/journal.pone.0292926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.10.2023. Verfasst von Ivan Pavlinov und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States of America. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Nervous System Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to model human neurological tissues in vitro has been a major hurdle to effective drug development for neurological disorders. iPSC-derived brain organoids have emerged as a compelling solution to this problem as they have the potential to relevantly model the protein expression pattern and physiology of specific brain regions. Although many protocols now exist for the production of brain organoids, few attempts have been made to do an in-depth kinetic evaluation of expression of mature regiospecific markers of brain organoids. To address this, we differentiated midbrain-specific brain organoids from iPSC-lines derived from three apparently healthy individuals using a matrix-free, bioreactor method. We monitored the expression of midbrain-specific neuronal markers from 7 to 90-days using immunofluorescence and immunohistology. The organoids were further characterized using electron microscopy and RNA-seq. In addition to serving as a potential benchmark for the future evaluation of other differentiation protocols, the markers observed in this study can be useful as control parameters to identify and evaluate the disease phenotypes in midbrain organoid derived from patient iPSC-lines with genetic neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsNervous System DiseasesHumansMesencephalonBrainOrganoidsCell Differentiation

Autor:innen und Institutionen

  • National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States of America.
  • Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • 3Dnamics, Inc., Baltimore, MD, United States of America.

ORCID-Profile: Ivan Pavlinov, Joshua Abbott, Wei Zheng

Förderung

  • National Center for Advancing Translational Sciences

Zitieren

APA

Pavlinov, I., Tambe, M., Abbott, J., Nguyen, H. N., Xu, M., Pradhan, M., Farkhondeh, A., & Zheng, W. (2023). In depth characterization of midbrain organoids derived from wild type iPSC lines. PLOS ONE, 18(10), e0292926. https://doi.org/10.1371/journal.pone.0292926

Vancouver

Pavlinov I, Tambe M, Abbott J, Nguyen HN, Xu M, Pradhan M, et al. In depth characterization of midbrain organoids derived from wild type iPSC lines. PLOS ONE. 2023;18(10):e0292926. doi:10.1371/journal.pone.0292926

BibTeX
@article{Pavlinov2023,
  author = {Pavlinov, Ivan and Tambe, Mitali and Abbott, Joshua and Nguyen, Ha Nam and Xu, Miao and Pradhan, Manisha and Farkhondeh, Atena and Zheng, Wei},
  title = {In depth characterization of midbrain organoids derived from wild type iPSC lines},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {10},
  pages = {e0292926},
  doi = {10.1371/journal.pone.0292926}
}
Kostenlos starten →